Cargando…

Opposing inflammatory biomarker responses to sleep disruption in cancer patients before and during oncological therapy

BACKGROUND: Sleep disruption is known to be highly prevalent in cancer patients, aggravated during oncological treatment and closely associated with reduced quality of life, therapeutic outcome and survival. Inflammatory factors are associated with sleep disruption in healthy individuals and cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Delmy, Andersson, Bengt-Åke, Lewin, Freddi, Jensen, Lasse D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534604/
https://www.ncbi.nlm.nih.gov/pubmed/36213755
http://dx.doi.org/10.3389/fnins.2022.945784